The relationship between cellular mediators (IL-1β, IFN–γ, MMP-9) in Iraqi women with breast cancer
Keywords:
Breast cancer, IL-1β, IFN-γ, MMP-9Abstract
Breast cancer is the most common type of cancer in Iraq. The incidence of breast cancer has increased among Iraqi women in the past two decades, as it represents one of the main threats to women's health. This steady aimed To evaluate the level of some immune factors Interleukin-1β (IL-1β), Interferon- γ (IFN–γ), and Matrix metalloproteinase-9 (MMP-9), and find the relationship between these immune factors in Iraqi women diagnosed with breast cancer. Material and method Fifty women diagnosed with breast cancer were enrolled in this study in addition to 25 healthy individuals as a control group. Level (IL-1β, IFN-γ, MMP-9) was measured using ELISA technology. Conclusion The expression level of (IL-1β, IFN-γ, MMP-9) increased in women with breast cancer in different age groups, but the age group (40-49) also recorded the highest expression of these cellular mediators. Regarding the relationship of (MMP-9), it was not significant with (IL-1β), but it was significant with (IFN-γ) (p≤0.05), and about the relationship between (IL-1β) and (IFN-γ) it was no significant negatively, that Increased level of (IL-1β, IFN-γ, MMP-9) expression could be a predictive marker of breast cancer.
Downloads
References
Salman, A. O. (2021). Immunogenetic Study on TGF-β, TGF-βRIII and HLA-G Genes among Iraqi Women with Breast Cancer. Ph.D Thesis. College of Ibn Al-Haitham. University of Baghdad..
Wan, R., Wang, Z. W., Li, H., Peng, X. D., Liu, G. Y., Ou, J. M., & Cheng, A. Q. (2017). Human leukocyte antigen-G inhibits the anti-tumor effect of natural killer cells via immunoglobulin-like transcript 2 in gastric cancer. Cellular Physiology and Biochemistry, 44(5), 1828-1841.
Ebbing EA, van der Zalm AP, Steins A, Creemers A, Hermsen S, Rentenaar R, Klein M, Waasdorp C, Hooijer GKJ, Meijer SL, et al. Stromal-derived interleukin 522 H. HERNANDEZ-VARGAS ET AL. 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci. 2019;116:2237–2242
Rasheed, R. A. (2021), Immunogenetic Study of Patients with Gastrointestinal Tract Cancer in Iraq.PhD. thesis. College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad.146p.
Wan, R., Wang, Z. W., Li, H., Peng, X. D., Liu, G. Y., Ou, J. M., & Cheng, A. Q. (2017). Human leukocyte antigen-G inhibits the anti-tumor effect of natural killer cells via immunoglobulin-like transcript 2 in gastric cancer. Cellular Physiology and Biochemistry, 44(5), 1828-1841.
Abdulkareem, Z.J. and Al-Abassi, H.M. (2019) ‘Serum Level of ST2 with Gene’s Distal Promoter Polymorphism in Iraqi Females with Breast Cancer’, Journal of Pharmaceutical Sciences and Research, 11(6), pp. 2333–2340.
Algire, C. et al. (2012) ‘Metformin reduces endogenous reactive oxygen species and associated DNA damage’, Cancer Prevention Research, 5(4), pp. 536–543.
Almalki, S.G. and Agrawal, D.K. (2016) ‘Effects of matrix metalloproteinases on the fate of mesenchymal stem cells’, Stem cell research & therapy, 7(1), pp. 1–12.
Alwan, N.A.S., Tawfeeq, F.N. and Muallah, F.H. (2017) ‘Breast cancer subtypes among Iraqi patients: identified by their Er, Pr and Her2 Status’, Journal of the Faculty of Medicine Baghdad, 59(4), pp. 303–307.
Aquino-López, A. et al. (2017) ‘Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines’, Frontiers in immunology, 8, p. 391.
Artis, D. and Spits, H. (2015) ‘The biology of innate lymphoid cells’, Nature, 517(7534), pp. 293–301.
Augoff, K. et al. (2022) ‘MMP9: A Tough Target for Targeted Therapy for Cancer’, Cancers, 14(7), p. 1847.
Awatef, M. et al. (2011) ‘Association between body mass index and risk of breast cancer in Tunisian women’, Annals of Saudi medicine, 31(4), pp. 393–397.
Ayers, M. et al. (2017) ‘IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade’, The Journal of clinical investigation, 127(8), pp. 2930–2940.
Baroja-Mazo, A. et al. (2014) ‘The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response’, Nature immunology, 15(8), pp. 738–748.
Chauvin, J.-M. et al. (2015) ‘TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients’, The Journal of clinical investigation, 125(5), pp. 2046–2058.
Chetty, C. et al. (2012) ‘MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells’, Cellular signalling, 24(2), p. 549.
Diskin, B. et al. (2020) ‘PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer’, Nature immunology, 21(4), pp. 442–454.
Dofara, S.G., Chang, S.-L. and Diorio, C. (2020) ‘Gene polymorphisms and circulating levels of MMP-2 and MMP-9: a review of their role in breast cancer risk’, Anticancer Research, 40(7), pp. 3619–3631.
Du, W. et al. (2021) ‘IFNγ signaling integrity in colorectal cancer immunity and immunotherapy’, Cellular & Molecular Immunology, pp. 1–10.
Fiotti, N. et al. (2005) ‘MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration’, Genetics in Medicine, 7(4), pp. 272–277.
Fouad, Y.A. and Aanei, C. (2017) ‘Revisiting the hallmarks of cancer’, American journal of cancer research, 7(5), p. 1016.
García-Tuñón, I. et al. (2007) ‘Influence of IFN-gamma and its receptors in human breast cancer’, BMC cancer, 7(1), pp. 1–11.
Garlanda, C., Dinarello, C.A. and Mantovani, A. (2013) ‘The interleukin-1 family: back to the future’, Immunity, 39(6), pp. 1003–1018.
Gato-Cañas, M. et al. (2017) ‘PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity’, Cell reports, 20(8), pp. 1818–1829.
Hernandez-Vargas, H. et al. (2020) ‘Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers’, Epigenetics, 15(5), pp. 511–523.
Huang, H. (2018) ‘Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances’, Sensors, 18(10), p. 3249.
Imai, D. et al. (2019) ‘IFN-γ promotes epithelial-mesenchymal transition and the expression of PD-L1 in pancreatic cancer’, Journal of Surgical Research, 240, pp. 115–123.
Javadian, M. et al. (2019) ‘The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis’, Journal of Cellular Physiology, 234(5), pp. 5399–5412.
Kessenbrock, K., Plaks, V. and Werb, Z. (2010) ‘Matrix metalloproteinases: regulators of the tumor microenvironment’, Cell, 141(1), pp. 52–67.
Lachowski, D. et al. (2019) ‘Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis’, Scientific reports, 9(1), pp. 1–9.
Lee, S.-A. et al. (2007) ‘Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies’, Cancer Epidemiology and Prevention Biomarkers, 16(11), pp. 2464–2470.
Lee, S. et al. (2014) ‘A high-throughput assay of NK cell activity in whole blood and its clinical application’, Biochemical and Biophysical Research Communications, 445(3), pp. 584–590.
Li, H. et al. (2017) ‘The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis’, Oncology letters, 14(5), pp. 5865–5870.
Li, Hongzhong et al. (2013) ‘Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway’, Toxicology letters, 220(3), pp. 219–228.
Li, J. et al. (2017) ‘Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn’s disease patients’, Clinical & Experimental Immunology, 190(1), pp. 143–153.
Li, T. et al. (2021) ‘Overexpression of Neutrophil MMP-9 and HIF-1α May Contribute to the Finger-Like Projections Formation and Histo-Pathogenesis in Nasal Inverted Papilloma’, Journal of Inflammation Research, 14, p. 2979.
Li, X. et al. (2017) ‘miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma’, International journal of oncology, 50(4), pp. 1097–1108.
Milosevic, V. et al. (2020) ‘Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5’, International Journal of Cancer, 146(1), pp. 192–207.
Mon, N.N., Senga, T. and Ito, S. (2017) ‘Interleukin‑1β activates focal adhesion kinase and Src to induce matrix metalloproteinase‑9 production and invasion of MCF‑7 breast cancer cells’, Oncology letters, 13(2), pp. 955–960.
Nutter, F. et al. (2014) ‘Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line’, Endocrine-related cancer, 21(2), pp. 327–341.
Opdenakker, G., Van den Steen, P.E. and Van Damme, J. (2001) ‘Gelatinase B: a tuner and amplifier of immune functions’, Trends in immunology, 22(10), pp. 571–579.
Quaranta, M. et al. (2007) ‘MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer’, Anticancer research, 27(5B), pp. 3593–3600.
Quintero-Fabián, S. et al. (2019) ‘Role of matrix metalloproteinases in angiogenesis and cancer’, Frontiers in oncology, 9, p. 1370.
Rébé, C. and Ghiringhelli, F. (2020) ‘Interleukin-1β and cancer’, Cancers, 12(7), p. 1791.
Salman (2021) ‘HLA-G 14-bp Insertion/Deletion (In/Del) Polymorphism in Breast Cancer Iraqi Arabian Women.’, Indian Journal of Forensic Medicine & Toxicology, 15(3), p. 1109.
Sand, J.M. et al. (2013) ‘MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis–validation of two novel biomarker assays’, PloS one, 8(12), p. e84934.
Somiari, S.B. et al. (2006) ‘Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer’, Cancer letters, 233(1), pp. 98–107.
Steel, R.G.D. and Torrie, J.H. (1960) ‘Principles and procedures of statistics.’, Principles and procedures of statistics. [Preprint].
Szulc-Kielbik, I. and Klink, M. (2022) ‘Polymorphonuclear Neutrophils and Tumors: Friend or Foe?’, in Interaction of Immune and Cancer Cells. Springer, pp. 141–167.
Templeton, Z.S. et al. (2015) ‘Breast cancer cell colonization of the human bone marrow adipose tissue niche’, Neoplasia, 17(12), pp. 849–861.
Tulotta, C. et al. (2019) ‘Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment’, Clinical Cancer Research, 25(9), pp. 2769–2782.
Tulotta, C. and Ottewell, P. (2018) ‘The role of IL-1B in breast cancer bone metastasis’, Endocrine-related cancer, 25(7), pp. R421–R434.
Vannini, F., Kashfi, K. and Nath, N. (2015) ‘The dual role of iNOS in cancer’, Redox biology, 6, pp. 334–343.
Wan, R., Wang, Z. W., Li, H., Peng, X. D., Liu, G. Y., Ou, J. M., & Cheng, A.Q. (2017) ‘Human leukocyte antigen-G inhibits the anti-tumor effect of natural killer cells via immunoglobulin-like transcript 2 in gastric cancer’, Cellular Physiology and Biochemistry, 44(5), pp. 1828–1841.
Weaver, A.M. (2006) ‘Invadopodia: specialized cell structures for cancer invasion’, Clinical & experimental metastasis, 23(2), pp. 97–105.
Wu, Y. et al. (2013) ‘Monocyte/macrophage‐elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions’, Hepatology, 57(3), pp. 1107–1116.
Wu, Z. et al. (2008) ‘Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer’, International journal of cancer, 122(9), pp. 2050–2056.
Yousef, E.M. et al. (2014) ‘MMP-9 expression varies according to molecular subtypes of breast cancer’, BMC cancer, 14(1), pp. 1–12.
Zhu, Y. et al. (2015) ‘Antitumor enhancement by irradiated haploidentical donor lymphocyte infusion of mice with melanoma’, Cellular Physiology and Biochemistry, 35(6), pp. 2181–2191.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
